Eledon Announces Completion of Enrollment in Phase 2 Bestow Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
Eledon宣佈完成了第2期Bestow臨床試驗的招募,評估Tegoprubart用於預防腎移植患者器官排斥。
Eledon Announces Completion of Enrollment in Phase 2 Bestow Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients
Eledon宣佈完成了第2期Bestow臨床試驗的招募,評估Tegoprubart用於預防腎移植患者器官排斥。
譯文內容由第三人軟體翻譯。